30 秒でわかる
The speakers discuss a hoped-for convergence of biotechnology and the challenge of understanding and modifying molecular interaction networks. The clip presents a research outlook rather than a specific validated treatment.
- 1Technology convergenceThe speaker predicts a convergence of biological technologies.
- 2Molecular networksMolecular interactions can be viewed together as networks.
- 3Research challengeChanging disease-associated networks is a research goal, not an established treatment in this clip.
ポイント
- The speaker predicts a convergence of biological technologies.
- Molecular interactions can be viewed together as networks.
- Changing disease-associated networks is a research goal, not an established treatment in this clip.
チャプターごとに整えた全文を読む
From interactions to intervention
The speaker describes a possible direction for biotechnology.
The interviewer asks whether biotechnology is entering a period of rapid change, moving from understanding biological systems toward intervening in them. The speaker expects multiple technologies to converge, but this is a forecast rather than a demonstrated timetable.
The speaker is excited by the possibility of editing or modifying biology to address health problems. Greater ability to intervene does not itself establish that a particular treatment is safe or effective.
The speaker usually thinks in terms of molecular interactions, but says those interactions can also be studied as networks that contribute to an organism’s traits and states.
Some biological states are associated with disease. The speaker argues that understanding how to modify interaction networks is an important area for future research.
同じチャンネルの記事
1:49:40EN
1:28:36EN
3:13:44EN
2:40:58EN
1:25:56EN
2:51:22EN